A Study of PRT811 in Participants With Advanced Solid Tumors, Gliomas and Myelofibrosis

Conditions:   Advanced Solid Tumor;   Recurrent Glioma;   Myelofibrosis Intervention:   Drug: PRT811 Sponsor:   Prelude Therapeutics Not yet recruiting

Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials